🇺🇸 FDA

Company profile · Sponsor

Esteve

Esteve Pharmaceuticals

E196698 · EMA pharma MONTROUGE, FR
Pipeline
1
Drugs
0
Patents
0

Quick answer

Esteve (E196698) is a pharma company. headquartered in MONTROUGE, FR. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E196698
Exchange EMA
Company type pharma
Headquarters MONTROUGE, FR

Pipeline (1)

Search pipeline →

  1. Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients with MPSIIIA.

    Esteve

    Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)

    phase 2 other active

    1 trial

Frequently asked questions

What is Esteve?

Esteve (E196698) is a pharma company. headquartered in MONTROUGE, FR. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Esteve sponsor?

We track 1 ClinicalTrials.gov-linked program for Esteve, including Phase I/II safety, tolerability and initial efficacy study of adeno-associated viral vector serotype 9 containing human sulfamidase gene after intracerebroventricular administration to patients with MPSIIIA.. Open each program for phase, modality, NCT IDs, and indication details.

Where does Esteve company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.